ESTRO PT 2018

Therapeutic Results – IMPT vs. IMRT in Oropharynx

35 pts IMPT; 46 pts IMRT

Patient-reported Outcome (PRO): Changes in taste and appetite during the subacute and chronic phases favored IMPT (all P<.048)

Need for prospective trials (ongoing)